Comparative proteomic and phosphoproteomic profiling of pancreatic adenocarcinoma cells treated with CB1 or CB2 agonists.
about
The Therapeutic Aspects of the Endocannabinoid System (ECS) for Cancer and their Development: From Nature to Laboratory.Pancreatic cancer stromal biology and therapy.Cannabinoid WIN55, 212-2 induces cell cycle arrest and inhibits the proliferation and migration of human BEL7402 hepatocellular carcinoma cellsProteome-Wide Protein Expression Profiling Across Five Pancreatic Cell Lines.An integrated approach identifies new oncotargets in melanoma.
P2860
Comparative proteomic and phosphoproteomic profiling of pancreatic adenocarcinoma cells treated with CB1 or CB2 agonists.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Comparative proteomic and phos ...... ated with CB1 or CB2 agonists.
@en
Comparative proteomic and phos ...... ated with CB1 or CB2 agonists.
@nl
type
label
Comparative proteomic and phos ...... ated with CB1 or CB2 agonists.
@en
Comparative proteomic and phos ...... ated with CB1 or CB2 agonists.
@nl
prefLabel
Comparative proteomic and phos ...... ated with CB1 or CB2 agonists.
@en
Comparative proteomic and phos ...... ated with CB1 or CB2 agonists.
@nl
P2093
P2860
P356
P1433
P1476
Comparative proteomic and phos ...... ated with CB1 or CB2 agonists.
@en
P2093
Daniela Cecconi
Ilaria Dando
Jessica Brandi
Marta Palmieri
Massimo Donadelli
P2860
P304
P356
10.1002/ELPS.201200402
P577
2013-04-11T00:00:00Z